Skip to Main Content
Book cover for Oxford Handbook of Genitourinary Medicine, HIV, and Sexual
Health (2 edn) Oxford Handbook of Genitourinary Medicine, HIV, and Sexual Health (2 edn)

A newer edition of this book is available.

Close

Contents

Disclaimer
Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always … More Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Haematological disorders 562

Persistent generalized lymphadenopathy 564

Common haematological abnormalities may lead to consideration of HIV as the cause. Direct effect of HIV itself or 2° to concurrent infection, malignancy, and therapeutic agents. Common findings are ↓ haemopoiesis, altered coagulation, and immune-mediated cytopenias with ↓ bone marrow cellularity and dysplasia.

Most common form of cytopenia and an independent prognostic factor. Usually due to ↓ erythropoiesis, but other mechanisms (e.g. infection, drug toxicity, malignancy, dietary deficiencies, alcohol abuse, blood loss) may contribute. Chronic anaemia causes fatigue, exertional dyspnoea, and a hyperdynamic state which, if severe, may lead to angina, congestive cardiac failure, and confusion.

Examine and test for iron, vitamin B12, and folate deficiencies, haemolysis, and blood loss according to red cell indices. Eliminate possible causes by excluding infection and malignancy and reviewing drug therapy. Bone marrow examination may be required.

HIV-related: normocytic normochromic anaemia ↑ in frequency and severity as HIV progresses. May be a direct effect of HIV on bone marrow progenitor cells, ↓ erythropoietin production, and ↑ cytokines (inhibit haemopoiesis). Improves or normalizes with HAART provided that drug effects do not supervene.

Drug toxicity

Macrocytosis and normal haemoglobin—typical with zidovudine (AZT).

Macrocytic anaemia—caused by AZT and stavudine. AZT exerts broader myelosuppressive effects, more frequent in patients receiving higher doses (in ~1% receiving 500mg a day) and those with advanced disease. Anaemia may require blood transfusion following discontinuation of AZT. In patients with a low level of endogenous erythropoietin (<500IU/L), recombinant human erythropoietin may resolve anaemia, thereby ↓ need for transfusion.

Normocytic normochromic anaemia—associated with normal or ↓ reticulocyte count, 2° to bone marrow suppression. Causes include anaemia of chronic infection and drugs (e.g. ganciclovir, co-trimoxazole, amphotericin, and interferons).

Haemolytic anaemia—features are macrocytosis, ↓ haptoglobin, and ↑ lactic dehydrogenase, indirect bilirubin, and reticulocyte count. Common causes include drugs, e.g. dapsone (with methaemoglobinaemia), ribavirin, and primaquin. Glucose-6-phosphate dehydrogenase (G6PD) deficiency predisposes to dapsone and primaquin haemolysis. Autoimmune haemolytic anaemia (AIHA) with positive Coombs’ test also occurs.

Bone marrow infiltration (usually causes pancytopenia)

Opportunistic infection (OI)—most commonly Mycobaterium avium complex (also tuberculosis and cytomegalovirus).

Tumours—lymphoma and rarely Kaposi’s sarcoma.

B19 parvovirus infects erythroid precursors. In immune deficiency persistent infection may result in severe chronic normocytic normochromic anaemia. Diagnosed by detecting B19 parvovirus antibodies and DNA (by polymerase chain reaction) in serum and/or bone marrow. Responds well to high-dose IV immunoglobulins (0.4g/kg/day) which contain parvovirus antibodies, but may require repeated blood transfusions.

Occurs in up to 30%. May be result of drug toxicity, immune and non-immune destruction, or defective platelet production. Commonly an isolated haematological abnormality with ↑ levels of antiplatelet immunoglobulin. HIV-related immune thrombocytopenia is frequent early finding, tending to deteriorate as HIV progresses. Results from clearance of immunoglobulin-coated platelets by reticulo-endothelial system.

Exclude underlying causes, e.g. drug toxicity, liver disease, alcoholism, and lymphoma. In their absence the presence of normal or ↑ megakaryocytes on bone marrow examination is sufficient to diagnose HIV-induced thrombocytopenia.

Mild and asymptomatic—HAART, switch/discontinue implicated drugs.

Symptomatic or before surgical procedures—IV immunoglobulins, steroids, and HAART.

Substantial bleeding—packed red cells and platelet transfusion.

Rare, of unknown aetiology, usually seen in early stages of HIV infection. Characterized by hyaline microvascular deposits. Clinical features include fever, renal impairment, neurological deficit, and microangiopathic haemolytic anaemia. Mortality rate ~65% without treatment. However, good response to plasmapheresis, steroids, HAART, and antiplatelets (e.g. aspirin).

HIV directly implicated, especially in advanced stages. More commonly due to drug toxicity, associated infection, and bone marrow infiltration. Risk of bacterial infection ↑ significantly when absolute neutrophil count <500cells/μL. Drugs causing neutropenia include AZT, ganciclovir, co-trimoxazole, pentamidine, α-interferon, and chemotherapeutic agents.

Careful review of medication. Withdraw offending drug(s) if absolute neutrophil count <500cells/μL. If cause uncertain, consider bone marrow examination.

HAART: variable response.

Granulocyte colony-stimulating factor:

HIV-induced

drug-induced (if implicated drug cannot be reduced or stopped).

↑ risk of thrombotic disease associated with low CD4 counts, OIs, neoplasms, and HIV-associated autoimmune disorders.

High inflammatory state; increased D-dimer and cytokines are proposed factors in advanced disease.

Lupus anticoagulant may be detected with thromboembolic disease.

↓ levels of active protein S frequently found, although not associated with immune suppression.

Contributing prothrombotic factors include ↓ plasminogen activator inhibitor level, abnormal platelet aggregation, and ↑ von Willebrand factor.

Generalized lymphadenopathy involving ≥2 extra-inguinal sites persisting for more than 3 months. Of no prognostic significance, but other causes of generalized lymphadenopathy should be excluded. Occurs in up to 70% of patients within 1 year of seroconversion but may coexist with other manifestations of HIV infection. Lymph nodes usually symmetrical, >1cm in size, rubbery, and non-tender. May be accompanied by hepatosplenomegaly. Mediastinal lymphadenopathy usually has other causes.

Important diagnoses to consider in HIV-associated lymphadenopathy

Persistent generalized lymphadenopathy

Bacterial infections (including mycobacteria)

2° syphilis

Lymphoma

Histoplasmosis

Multicentric Castleman’s disease

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close